Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Leukemia Research|March 21, 2016
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotinUma Borate, Amitkumar Mehta, Vishnu Reddy, et al.
Current Hematologic Malignancy Reports|January 14, 2022
Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm ShiftSarah A Wall, Erin Stevens, Jennifer Vaughn, et al.
Blood Advances|September 21, 2019
Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 yearsUma Borate, Brianna A Norris, Abby Statler, et al.
Current Hematologic Malignancy Reports|May 3, 2021
IDH Inhibitors in AML-Promise and PitfallsHannah McMurry, Luke Fletcher, Elie Traer
Oncotarget|August 6, 2020
Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patientsMara W Rosenberg, Kevin Watanabe-Smith, Jeffrey W Tyner, et al.
Expert Review of Hematology|August 4, 2022
Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database studyBhavik J Pandya, Chi-Chang Chen, Catherine B McGuiness, et al.
Current Oncology Reports|January 29, 2020
Cell Death Pathways in Lymphoid MalignanciesLuke Fletcher, Edward Nabrinsky, Tingting Liu, et al.
International Journal of Hematology|September 12, 2014
Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experienceDeniz Peker, Vishwas Parekh, Ravikumar Paluri, et al.
Pageof 8